baber/WOPTO huggingface dataset:
Patent CZ-301553-B6 (CZ)
Title: Pharmaceutical composition based on ibuprofen and process for preparing thereof
Inventor: TARRU PUREZ MARIA TERESA
IPC: A61K47/48
Filed: 2001-02-26
Abstract: The present invention relates to a pharmaceutical composition based on ibuprofen and a process for the preparation thereof. The composition, in the form of powder, for administration in soluble form in water, has an acceptable taste is characterized in that it comprises, as active component, ibuprofen lysinate, in combination with cyclodextrin, and other pharmaceutically acceptable excipients. Its preparation process comprises: sieving separately the ibuprofen lysinate and the cyclodextrin, mixing these components, submitting the mixture to an ultra-rapid mixing, and sieving and mixing the resulting mixture along with the pharmaceutically acceptable excipients.
Patent CZ-299174-B6 (CZ)
Title: Panel reinforcing method of existing metal structure, ship with such reinforced panel and reinforced metal structure per se
Inventor: KENNEDY STEPHEN J
IPC: B63B9/00
Filed: 2001-08-21
Abstract: The present invention relates to a method of reinforcing a panel (10) of an existing metal structure comprising the steps of attaching a reinforcing metal layer (20) to said metal panel in spaced apart relation to thereby form at least one cavity (40) between an inner surface (18) of said metal panel (10) and an inner surface (22) of said reinforcing metal layer (20) turned toward said panel (10) inner surface (18), injecting an intermediate layer comprised of an uncured plastics material into said at least one cavity (40), and curing said plastics material so that it adheres to said inner surfaces (18, 22) of said metal panel (10) and said reinforcing metal layer (20) with sufficient strength to transfer shear loads between the metal panel (10) and reinforcing layer (20). The present invention further relates to a ship provided with a panel reinforced by the above-described process, and to a reinforced metal structure produced in the above-indicated manner.
Patent CZ-304479-B6 (CZ)
Title: Process for preparing and stabilization of kaolin froth
Inventor: PTÁČEK PETR
IPC: C04B14/10
Filed: 2013-05-06
Abstract: In the present invention, there is described a process for preparing and stabilization of a solid kaolin froth by mixing a kaolin suspension with a froth made of a surfactant with water while stabilization of the kaolin froth is achieved by addition of aggregates, optionally in the mixture thereof with another porous substance followed up with a finish treatment by drying and firing. The process according to the present invention provides preparation of a solid froth with extremely low volume weight and a high chemical and thermal stability. The froth can be used not only in an environment of high temperature and pressure, but also as a thermally insulating and soundproof material.
Patent CZ-307242-B6 (CZ)
Title: A method of distributing a working liquid to two different pressure zones, a method of distributing a heat-exchange liquid to two different temperature zones, and a device for implementing these methods
Inventor: HALADA MICHAL
IPC: G21K1/00
Filed: 2014-05-28
Abstract: The invention relates to a method of distributing a working/heat-exchange liquid to two zones of a different pressure or temperature, wherein the working/heat exchange liquid in the membrane chamber (1) is brought into contact with at least one membrane (4) with negative pressure resistance and/or negative thermal resistance, which results in the working liquid flowing from the area of lower pressure on one side of the membrane (4) into the area of higher pressure on the other side of the membrane (4) without causing external work, or which results in the heat from the heat-exchange liquid flowing from the area of lower temperature on one side of the membrane (4) into the area of higher temperature on the other side of the membrane (4). The invention further relates to a device for implementing this method comprising the membrane chamber (1) filled with the working/heat exchange liquid which is divided into two portions by at least one membrane (4) with negative pressure resistance and/or negative thermal resistance.
Patent CZ-305663-B6 (CZ)
Title: Process for preparing beer collagenous jelly and use thereof
Inventor: Chromík Jindřich
IPC: C12C12/00
Filed: 2014-07-11
Abstract: He process for preparing beer collagenous jelly for the need of beer, food, beverage, cosmetic and medicinal industries, according to the present invention is characterized in that animal biomaterial containing collagen is extracted by biological extraction medium being selected from the group consisting of beer, alcohol-free beer or wine at a temperature in the range of 10 to 43 degC for a period of 24 to 36 hours, depending on the collagen content in the biological material. The animal biomaterial is selected from the group consisting of pig, chicken or fish skins. After vigorous washing, the biomaterial is at least once extracted with a biological extraction medium in weight ratio to the biological material ranging from 1:0.2 to 0.4, in the presence of 0.5 to 1.5 percent by weight of 3 percent hydrogen peroxide, based on the weight of the extracted biomaterial, wherein the extraction medium contains 0.5 to 15 percent of ethyl alcohol according to the kind of the extraction medium used for extraction. The thus obtained extract is the let to collagen at a temperature in the range of 0 to 10 degC for further use. For the preparation of beverages, the extract can be used prior as well as after collagenation.
Patent CZ-307342-B6 (CZ)
Inventor: Erban Tomáš
IPC: G01N33/483
Filed: 2016-10-19
Abstract: Vynález se týká způsobu určení vlivu xenobiotika/xenobiotik na plod včely, zejména včely medonosné, v průběhu její metamorfózy. Přitom se u homogenizovaného vzorku včel ve stadiu metamorfózy a/nebo líhnoucích se včel a/nebo dospělých úlových včel včelstva, které bylo vystaveno danému xenobiotiku/xenobiotikům proteomickou analýzou zjišťuje množství alespoň jednoho z proteionových markerů uvedených v seznamu proteinových markerů v podstatě vynálezu, a tímto způsobem zjištěné množství proteinového markeru/proteinových markerů se srovnává se stejným způsobem zjištěným množstvím stejného/stejných proteinových markerů z homogenizovaného vzorku včel ve stadiu metamorfózy a/nebo líhnoucích se včel a/nebo úlových včel včelstva, které nebylo danému xenobiotiku/xenobiotikům vystaveno, nebo s předem stanoveným prahem.
Patent CZ-309135-B6 (CZ)
Title: Housing for electrical equipment, especially for the surface of a moving area
Inventor: HANZAL PŘEMYSL
IPC: G08G1/095
Filed: 2018-05-24
Abstract: Electrical device housing (5), for placing in the surface of a road, which consists of a body (3) with a single internal cavity (2) with an electrical device (5), adapted for data collection and wireless communication with the superior system, the cavity (2) with the inserted electrical device (5) is covered by a removable lid (1). The body (3) is preferably formed by paving, preferably prefabricated paving, for example concrete interlocking paving. The electrical device (5) consists of a parking sensor preferably resiliently seated in the cavity (2) of the body (3), for example in a silicone sealant.
Patent CZ-299029-B6 (CZ)
Title: Mixture of piperidinylaminomethyl trifluoromethyl cyclic ether compounds, and processes as well as intermediates for its preparation
Inventor: CARON STUPHANE
IPC: A61K31/453
Filed: 2000-10-17
Abstract: The present invention relates to a novel process for the preparation of a diastereomeric mixture of piperidinylaminomethyl trifluoromethyl cyclic ether compounds of the general formulae Ia and Ib: and pharmaceutically acceptable salts thereof, wherein Re1 represents an alkyl group containing 1 to 6 carbon atoms; Re2 denotes an alkyl group containing 1 to 6 carbon atoms, a haloalkyl group containing 1 to 6 carbon atoms in the alkyl moiety or phenyl or substituted phenyl; Re3 represents hydrogen or halo; m is zero, one or two, and wherein said mixture is highly enriched in the compound of the general formula Ia, and to novel processes for the preparation and purification of intermediate compounds useful in the preparation of compounds of the general formulae Ia and Ib.
Patent CZ-291109-B6 (CZ)
Title: Condensed thienopyrimidine derivative exhibiting phosphodiesterase inhibiting activity, process of its preparation and pharmaceutical preparation in which the derivative is comprised
Inventor: JONAS ROCHUS
IPC: A61P15/10
Filed: 1999-04-23
Abstract: In the present invention there is disclosed condensed thienopyrimidine derivative of the general formula I, wherein Re1 and Re2 represent independently on each other a hydrogen atom, A, OA, Hal or Re1 and Re2 together represent also   alkylene containing 3 to 5 carbon atoms, {-O-CHi2-CHi2-}, {-CHi2-O-CHi2-}, {-O-CHi2-O-} or {-O-CHi2-CHi2-O-}, X denotes either the Re4, Re5 group being substituted with the group Re7 or Re6 group, Re4 represents a linear or branched alkylene having 1 to 10 carbon atoms, whereby one or two CHi2 groups can be optionally substituted with {-CH=CH-}, Re5 denotes the group cycloalkyl containing 5 to 12 carbon atoms or cycloalkylene having 5 to 12 carbon atoms, Re6 is phenyl or phenylmethyl, Re7 represents {COOH}, {COOA}, {CONHi2}, {CONHA}, {CON(A)i2} or CN, A denotes alkyl containing 1 to 6 carbon atoms and Hal is fluorine, chlorine, bromine or iodine, and physiologically acceptable salts. These compounds are phosphodiesterase inhibitors and are therefore suitable for preparation of pharmaceutical preparations intended for treating diseases of heart circulation system and for treating potency disorders.
Patent SK-288422-B6 (SK)
Title: Omega-aminoalkylamides of (R)-2-arylpropionic acid and their use as a medicament
Inventor: ALLEGRETTI MARCELLO
IPC: C07D451/04
Filed: 2002-02-25
Abstract: (R)-2-arylpropionamide compounds of general formula (I) and their use as amedicament for the treatment of diseases involving C5a-induced chemotaxis of polymorphonucleate leukocytes and monocytes. The compounds can be used for the treatment of psoriasis, pemphigus and pemphigoid, rheumatoid arthritis, intestinal chronic inflammatory pathologies, acute respiratory distress syndrome, idiopathic fibrosis, cystic fibrosis, chronic obstructive pulmonary disease and glomerulonephritis and also for the prevention and the treatment of injury caused by ischemia and reperfusion.
Patent EP-1340276-B8 (EP)
Inventor: SUGIURA HIROSHI
IPC: H01M8/04
Filed: 2001-10-02
Granted: 2009-03-25
Abstract: A power source system (1) includes a fuel cell (40) and a battery (20) connected in parallel. A DC-DC converter (30) is connected to the battery (20) side. A maximum output ratio of the fuel cell (40) and the battery (20) is set in a range in which the output of the fuel cell falls within 65 to 80% of the total output. Accordingly, electric power loss due to the DC-DC converter (30) is controlled, whereby a high energy efficiency can be achieved.
Patent EP-1513618-B8 (EP)
Inventor: GARNER JAMES WILLIAM
IPC: B05B7/24
Filed: 2003-05-15
Granted: 2008-10-08
Abstract: A method for coating vehicular radiators with an ozone depleting manganese oxide catalyst in slurry form utilizes a robotic arm with multiple spray heads for spraying the face of the radiator. Each head is in fluid communication with its own dedicated peristaltic pump. The pumps are independently valved into and out of fluid communication with select heads as a function of the spray pattern effected by robotic arm movement.
Patent EP-2246704-B8 (EP)
Inventor: ZUPPIGER ADELRICH
IPC: B01L3/02
Filed: 2009-04-30
Granted: 2012-06-06
Abstract: The present invention pertains to a pipetting system (1) comprising: at least one pipetting channel (2) for pipetting of fluids including a channel pump (3) having at least one tip-sided port (6) connected to a pipetting tip (4) by means of a tip-sided pump conduit (5) for generating a positive or negative pressure in said pipetting tip (4) and at least one reservoir-sided port (7) connected to a system fluid reservoir (9) by means of a reservoir-sided pump conduit (8), said channel pump (3) exhibiting a fluid backflow caused by a pressure difference in the tip- and reservoir-sided pump conduits (5,8) resulting in an effective flow rate (F eff ) compared to a nominal flow rate (F nom ); a controller (17), set up to control the following steps: determining a pressure difference (p) between said tip- and reservoir sided pump conduits (5,8); based on said pressure difference (p), determining a volume difference (V) between a nominal volume (V nom ) and an effective volume (V eff ) pipetted by operating the channel pump (3) during a pipetting period (T p ) at said nominal flow rate (F nom ), said effective volume (V eff ) being reduced compared to said nominal volume (V nom ) due to said fluid backflow; based on said determined volume difference (V), determining a period extension (T), the period extension (T) being adapted for pipetting of said volume difference (V); pipetting fluid during an extended pipetting period (T tot ) extending said pipetting period (T p ) by said period extension (T tot ) by operating said channel pump (3) at said nominal flow rate (F nom ). It further relates to a method for pipetting of fluids as performed by the controller (17). It yet further relates to a method for calibrating a pipetting system (1) which comprises the steps of: providing such pipetting system (1); inhibiting fluid flow through said channel pump (3); operating the channel pump (3) at at least one nominal flow rate (F nom ) and determining at least one pressure difference (p') in said tip- reservoir-sided pump conduits (5,8); determining at least one blocked-condition nominal flow rate (F' nom ) achieved by operating the channel pump (3) and identifying the blocked-condition nominal flow rate (F' nom ) as fluid backflow rate (F' back ); establishing a relationship between said determined pressure difference (p') and said fluid backflow rate (F' back ).
Patent BR-PI0413266-B8 (BR)
Title: Composição de concentrado herbicida de alta potência, e método para controle de vegetação indesejável
Inventor: HOLGER TANK
IPC: A01N57/00
Filed: 2004-02-06
Abstract: "FORMULAÇÕES HERBICIDAS DE GLIFOSATO DE ALTA POTÊNCIA E BAIXA VISCOSIDADE". A presente invenção refere-se a uma formulação herbicida de alta potência contendo altas concentrações de sal de monoetilamina ou de dimetilamina de glifosato e um ou mais tensoativos selecionados para aumentar a atividade herbicida dos sais de glifosato. As formulações exibem viscosidade significativamente mais baixa à altas concentrações.
Patent BR-PI0608853-B8 (BR)
Title: composições farmacêuticas e processo para a fabricação de microgrânulos de rifaximina gastrorresistentes
Inventor: ERNESTO PALAZZINI
IPC: A61K9/16
Filed: 2006-03-06
Abstract: composições farmacêuticas gastrorresistentes contendo rifaximina, uso de microgrânulos gastrorresistentes contendo rifaximina e processo para a fabricação das primeiras na forma de microgrânulos gastrorresistentes. a presente invenção refere-se a formulações farmacêuticas contendo rifaximina na forma de microgrânulos produzidos gastrorresistentes por um polímero insolúvel em valores de ph entre 1,5 e 4,0 e solúveis em valores de ph entre 5,0 e 7,5, mediante sua preparação e mediante seu uso na fabricação de preparações medicinais úteis no tratamento de doenças intestinais inflamatórias (ibd) e principalmente doença de crohn.
Patent BR-PI0703785-B8 (BR)
Title: Acionamento auxiliar
Inventor: WILLIAM S THOME
IPC: B02C13/00
Filed: 2007-10-31
Abstract: ACIONAMENTO AUXILIAR. Um aparelho incluindo um mecanismo de conexão de carcaça configurado para ser atuado entre um estado conectado a uma carcaça e um estado desconectado e um atuador configurado para mover o primeiro mecanismo, enquanto o primeiro mecanismo estiver no estado conectado para mover a carcaça.
Patent BR-PI0919827-B8 (BR)
Title: processos para aumentar o rendimento de uma reação de peguilação de r-methug-csf processo para a produção em escala grama de peg- r-methug-csf
Inventor: ARUNA KHARE
IPC: C07K14/535
Filed: 2009-05-04
Abstract: processo aperfeiçoado para peguilação de proteínas. a presente invenção refere-se a um processo para aumentar o rendimento da reação de peguilação de r-meti-iug-csf compreendendo conjugar r-metihug a um peg aldeido em uma porção amina livre na extremidade n terminal da g-csf na presença de um agente redutor em uma solução de tampão de´peguilação compreendendo um poliol tendo a fórmula cnh2n+2on onde varia de 3 a 6 ou um carboidrato, ou um derivado do mesmo varia na faixa de 0,1% a 10% p/p.
Patent BR-112012009517-B8 (BR)
Title: processo de formação de espuma de poliuretano, composição espumável termoendurecível e uso da composição de agente de expansão polimérico
Inventor: BENJAMIN B CHEN
IPC: C08J9/14
Filed: 2010-10-20
Abstract: composições de agente de expansão de tetrafluorobuteno para espumas de poliuretano" é divulgado um agente de expansão para espumas termoendurecíveis. o agente de expansão é 2,4,4,4- tetrafluorobuteno-1 só ou em combinação com uma hidrofluoroolefina (hfo), hidrofluorocarbonetos (hfc), hidroclorofluoroolefina (hcfo) ou um hidrocarboneto. o agente de expansão é eficaz como agente de expansão na fabricação de espumas termoendurecíveis.
Patent BR-112012031627-B8 (BR)
Title: turbomotor fixado a um pilar da fuselagem de uma aeronave por intermédio de uma suspensão
Inventor: FRANÇOIS BELLABAL
IPC: B64D27/26
Filed: 2011-06-09
Abstract: turbomotor fixado a um pilar de fuselagem de uma aeronave por uma suspensão com segurança integrada a suspensão compreende um plano de suspensão dianteiro situado ao nível de um cárter intermediário do turbomotor e que liga esse último ao pilar, um plano de suspensão traseiro situado ao nível do cárter de escapamento do turbomotor e que liga esse último ao pilar, e um plano de suspensão intermediário com segurança integrada, situado entre os planos dianteiros e traseiro e que compreende pelo menos uma biela de ligação (10) entre o turbomotor de cárter externo estrutural e o pilar, montada com uma folga predeterminada no turbomotor que torna inoperante a biela de ligação enquanto a suspensão do plano traseiro funcionar. vantajosamente, a biela de ligação (10) do plano de suspensão intermediário é disposta entre o cárter externo e o pilar (7), e um elemento (18) realizado em um material flexível é associado á dita biela de ligação (10), de maneira a introduzir, por seu caráter elasticamente deformável, a dita folga predeterminada.
Patent BR-112013013910-B8 (BR)
Title: Arranjo de ventilador compreendendo um difusor e um ventilador de construção axial, radial ou diagonal
Inventor: MARKUS ENGERT
IPC: F04D29/66
Filed: 2011-12-16
Abstract: VENTILADOR/DIFUSOR COM ADMISSÃO CIRCULAR E SAÍDA DE SIMETRIA NÃO ROTACIONAL A presente invenção refere-se a um difusor (3) para um ventilador (2) em forma de construção axial radial ou diagonal, com uma abertura de entrada (10) e com uma abertura de saída (20) para um produto gasoso que flui desde a abertura da admissão (10) em uma direção de fluxo principal direcionado axialmente (S) de um compartimento interno do difusor (I) fechado por um alojamento externo (30), até a abertura de saída (20), sendo que a seção transversal (21) da abertura de saída (20) é maior do que a seção transversal (11) da abertura de entrada (10) e a seção transversal do compartimento interno do difusor (I), partindo do corte (11) da abertura de entrada aumenta para o corte (21) da abertura de saída (20), sendo que o alojamento externo (30) forma um componente difusor externo (AD) que limita externamente o compartimento difusor interno (I), sendo que o alojamento externo (30) forma um componente difusor externo (AD) que limita o compartimento interno difusor (I) na parte externa. Para conseguir de uma forma construtiva pouco complexa aprimoramentos do comportamento operacional relativo ao grau de ação e ruído e proposto que a seção transversal do componente difusor externo (AD) ao longo da direção de fluxo principal (S) converge de uma seção transversal (31) circular na abertura de entrada (10) para uma seção transversal (32) não circular na abertura de saída (20).
Patent BR-112014001573-B8 (BR)
Title: Molécula fv ao antígeno multivalente
Inventor: MELVYN LITTLE
IPC: C07K16/28
Filed: 2011-07-22
Abstract: MOLÉCULA FV DE LIGAÇÃO AO ANTÍGENO MULTIVALENTE. Em um aspecto, a presente invenção refere-se a uma molécula de ligação ao antígeno específica para albumina e CD3, compreendendo duas cadeias polipeptídicas, cada cadeia polipeptídica possuindo pelo menos quatro domínios variáveis em uma orientação que impede a formação de Fv e as duas cadeias polipeptídicas são dimerizadas uma com a outra, assim formando uma molécula de ligação ao antígeno multivalente. Em cada uma das duas cadeias polipeptídicas, os quatro domínios variáveis são dispostos na ordem VLA-VHB-VLB-VHA a partir do N-terminal para o C-terminal do polipeptídeo. As composições da molécula de ligação ao antígeno e os métodos de utilização da molécula de ligação ao antígeno ou as suas composições para o tratamento de várias doenças também são aqui fornecidos.
Patent NL-1043026-B9 (NL)
Title: Method and device for ecg monitoring and transmission
Inventor: SASO KOCESKI
IPC: A61B5/332
Filed: 2018-10-04
Granted: 2020-07-22
Abstract: Method and devices for acquiring bipolar bioelectrical signals, such as ECG signals of a human body, whereby left and right, time-synchronized independent and decoupled wearable devices have sensors for simultaneously collecting the signals from the left and the right side of the body. The devices process the collected signals into ECG data and communicate the processed data to a central device. The processing comprises that analog-to-digital convertors sample the signals. The devices wirelessly transmit the samples real-time or near-real time to a synchronization unit for synchronizing the samples. By continuously collecting ECG data of the left and the right side of the body, the chance of detecting abnormal ECG data increases , which leads to a more adequate detection of e.g. atria) fibrillation or stroke. A bracelet-like wearable device is proposed, which is comfortable to wear and intuitively and easily to use by a user.
Patent EP-1187613-B9 (EP)
Inventor: COLEMAN PATRICK L
IPC: A61P7/04
Filed: 2000-06-08
Granted: 2006-10-25
Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain amide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
Patent EP-1575531-B9 (EP)
Inventor: SANDROCK ALFRED
IPC: A61K47/42
Filed: 2003-09-26
Granted: 2012-02-22
Abstract: The present invention provides methods for the treatment, and pharmaceuticals for the use in the treatment, of mammalian subjects having, or at risk of developing, chronic demyelinating neuropathies, e.g., CIDP. The methods involve the administration of IFN-β therapeutics.
Patent EP-0716664-B9 (EP)
Inventor: SCHRADER DAVID
IPC: C08F287/00
Filed: 1994-08-04
Granted: 2006-06-21
Abstract: High impact polystyrene resins are provided having a surprisingly good combination of toughness and gloss characteristics. Such resins contain small (i.e., 0.1 to 0.4 micron) capsule morphology rubber particles in combination with relatively small (i.e., 0.25 to 1 micron) entanglement morphology rubber particles. It has been found that such resins are capable of providing Izod impact strength values in the range of 2.5 to 3.5 ft-lb/in (133.4 to 186.7 J/m) and higher at an overall volume average rubber size of less than 0.4 micron with corresponding gloss values in excess of 90 percent.